Published by
@ShahidNShah
@ShahidNShah
November 18 to November 20, 2020
Bergamo, Italy
This meeting aims to develop our understanding of the potential of liquid biopsies.This includes to support early detection of cancer; as prognostic, pharmacodynamic and predictive biomarkers of treatment efficacy and resistance; and for patient monitoring, including of minimal residual disease for early identification of disease relapse.It will also explore how liquid biopsies can be incorporated in cancer patient management and how implementation of liquid biopsies can change clinical practice.
Continue reading at eacr.org
November 18 to November 19, 2020
Bangkok, Thailand
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Media LLC. All Rights Reserved.
Built on Apr 29, 2024 at 4:03am